Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate study. (February 2020) - Anstee, Q.M.; Harrison, S.; Sanyal, Arun J.; Ratziu, V.; Rinella, M.; Younossi, Z.Y.; Boursier, J.; Francque, S.; Geerts, A.; Petta, S.; Bugianesi, E-; Romero-Gomez, M.; et al.